Yahoo Web Search

  1. FMCSA Extending Drug Clearinghouse Deadline For State Agencies

    Benzinga via Yahoo FinanceSep 05 15:49 PM

    State driver licensing agencies (SDLAs) will have three additional years to comply with federal drug and alcohol clearinghouse requirements if a proposed rule is approved. In a proposed ...

  2. RARE and partner GeneTx Biotherapeutics LLC announced that the FDA granted Orphan Drug and Rare Pediatric Disease designations to GTX-102 for the treatment of Angelman Syndrome, which ...

  3. Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?

    Motley Fool via Yahoo FinanceSep 05 15:12 PM

    In March, the Food and Drug Administration issued a complete response letter -- the agency's euphemism for a rejection letter -- to Sanofi (NASDAQ: SNY) and Lexicon Pharmaceuticals (NASDAQ ...

  4. AbbVie (NYSE: ABBV) announced last week that it's completely throwing in the towel on the experimental lung cancer drug after another failure in a late-stage clinical study. There are ...

  5. Ex-drug company CEO Martin Shkreli sues former investor

    Associated Press via Yahoo FinanceSep 06 21:02 PM

    Convicted former drug company CEO Martin Shkreli sued the son of one of his investors Friday in a dispute over losses from one of his failed hedge funds. The suit, filed in federal court ...

  6. WASHINGTON, Aug. 29, 2019 /PRNewswire/ -- https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements ...

  7. Puma Biotechnology Inc (NASDAQ: PBYI) shares advanced in premarket trading Wednesday on the back of an announcement concerning its breast cancer drug Nerlynx before falling after the ...

  8. Akari's Nomacopan Gets Orphan Drug Tag for Rare Disease

    Zacks via Yahoo FinanceSep 02 13:17 PM

    Akari Therapeutics, Plc AKTX announced that the FDA has granted an orphan drug designation to its lead pipeline candidate nomacopan for the treatment of hematopoietic stem cell transplantation-associated ...

  9. Novartis takes aim at Roche's star MS drug

    Reuters via Yahoo FinanceAug 30 9:40 AM

    Swiss drugmaker Novartis on Friday stepped up its challenge to Roche's multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town ...

  10. According to the complaint filed with the consent decree, the defendants unlawfully distributed unapproved new drugs, adulterated and misbranded dietary supplements and an...

  1. Ads
    related to drug